| Micellar Paclitaxel to Treat Severe Psoriasis (NCT00006276) | National Cancer Institute (NCI) | 2000-09-01 |
| Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (NCT00007878) | National Cancer Institute (NCI) | 2000-09-01 |
| Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer (NCT00006929) | National Cancer Institute (NCI) | 2000-09-01 |
| Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00006473) | National Cancer Institute (NCI) | 2000-09-01 |
| EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma (NCT00006222) | National Cancer Institute (NCI) | 2000-09-01 |
| Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT00006226) | National Cancer Institute (NCI) | 2000-09-01 |
| Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance (NCT00026663) | National Cancer Institute (NCI) | 2000-08-09 |
| Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma (NCT00006171) | National Cancer Institute (NCI) | 2000-08-07 |
| Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00019929) | National Cancer Institute (NCI) | 2000-08-01 |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967) | National Cancer Institute (NCI) | 2000-08-01 |
| SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer (NCT00006001) | National Cancer Institute (NCI) | 2000-08-01 |
| Lung Screening Study (NCT00006382) | National Cancer Institute (NCI) | 2000-08-01 |
| SU5416 in Treating Patients With Malignant Mesothelioma (NCT00006014) | National Cancer Institute (NCI) | 2000-08-01 |
| Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed (NCT00006006) | National Cancer Institute (NCI) | 2000-08-01 |
| SU5416 and Carboplatin to Treat Ovarian Cancer (NCT00006155) | National Cancer Institute (NCI) | 2000-08-01 |
| BMS-214662 in Treating Patients With Advanced Solid Tumors (NCT00006242) | National Cancer Institute (NCI) | 2000-07-01 |
| Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00006094) | National Cancer Institute (NCI) | 2000-07-01 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer (NCT00020267) | National Cancer Institute (NCI) | 2000-07-01 |
| Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction (NCT00006062) | National Cancer Institute (NCI) | 2000-07-01 |
| SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated (NCT00006003) | National Cancer Institute (NCI) | 2000-07-01 |
| Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer (NCT00006228) | National Cancer Institute (NCI) | 2000-07-01 |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma (NCT00006102) | National Cancer Institute (NCI) | 2000-07-01 |
| PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer (NCT00005916) | National Cancer Institute (NCI) | 2000-06-13 |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer (NCT00005908) | National Cancer Institute (NCI) | 2000-06-01 |
| Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas (NCT00005926) | National Cancer Institute (NCI) | 2000-06-01 |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer (NCT00005842) | National Cancer Institute (NCI) | 2000-06-01 |
| Celecoxib in Treating Patients With Bladder Cancer (NCT00006124) | National Cancer Institute (NCI) | 2000-06-01 |
| Voriconazole to Prevent Systemic Fungal Infections in Children (NCT00005912) | National Cancer Institute (NCI) | 2000-06-01 |
| Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors (NCT00020150) | National Cancer Institute (NCI) | 2000-06-01 |
| Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00020189) | National Cancer Institute (NCI) | 2000-06-01 |
| Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer (NCT00020254) | National Cancer Institute (NCI) | 2000-06-01 |
| Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma (NCT00005780) | National Cancer Institute (NCI) | 2000-06-01 |
| Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer (NCT00020176) | National Cancer Institute (NCI) | 2000-06-01 |
| O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma (NCT00005961) | National Cancer Institute (NCI) | 2000-06-01 |
| Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer (NCT00019916) | National Cancer Institute (NCI) | 2000-06-01 |
| FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer (NCT00020202) | National Cancer Institute (NCI) | 2000-06-01 |
| Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer (NCT00005970) | National Cancer Institute (NCI) | 2000-05-19 |
| Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine (NCT00026676) | National Cancer Institute (NCI) | 2000-05-01 |
| Thalidomide in Treating Patients With Myelofibrosis (NCT00015821) | National Cancer Institute (NCI) | 2000-05-01 |
| Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma (NCT00005976) | National Cancer Institute (NCI) | 2000-05-01 |
| Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles (NCT00005781) | National Cancer Institute (NCI) | 2000-05-01 |
| R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer (NCT00005843) | National Cancer Institute (NCI) | 2000-05-01 |
| Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery (NCT00006016) | National Cancer Institute (NCI) | 2000-05-01 |
| 506U78 in Treating Patients With Lymphoma (NCT00005080) | National Cancer Institute (NCI) | 2000-05-01 |
| Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer (NCT00006015) | National Cancer Institute (NCI) | 2000-05-01 |
| Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders (NCT02210858) | National Cancer Institute (NCI) | 2000-05-01 |
| Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer (NCT00005655) | National Cancer Institute (NCI) | 2000-04-28 |
| A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) (NCT00001938) | National Cancer Institute (NCI) | 2000-04-24 |
| Bone Mineral Density and Subsequent Cancer Risk (NCT00340262) | National Cancer Institute (NCI) | 2000-04-07 |
| 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma (NCT00005950) | National Cancer Institute (NCI) | 2000-04-01 |
| Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment (NCT00005811) | National Cancer Institute (NCI) | 2000-04-01 |
| O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma (NCT00004892) | National Cancer Institute (NCI) | 2000-04-01 |
| BMS-214662 in Treating Patients With Solid Tumors (NCT00005973) | National Cancer Institute (NCI) | 2000-04-01 |
| BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia (NCT00006213) | National Cancer Institute (NCI) | 2000-04-01 |
| 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma (NCT00005982) | National Cancer Institute (NCI) | 2000-04-01 |
| Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy (NCT00004853) | National Cancer Institute (NCI) | 2000-03-03 |
| Genetic Component of Handedness (NCT00005003) | National Cancer Institute (NCI) | 2000-03-01 |
| SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer (NCT00005818) | National Cancer Institute (NCI) | 2000-03-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00005838) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma (NCT00004244) | National Cancer Institute (NCI) | 2000-03-01 |
| Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells (NCT00020072) | National Cancer Institute (NCI) | 2000-03-01 |
| Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps (NCT00005094) | National Cancer Institute (NCI) | 2000-03-01 |
| Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma (NCT00019864) | National Cancer Institute (NCI) | 2000-03-01 |
| Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer) (NCT00019955) | National Cancer Institute (NCI) | 2000-03-01 |
| Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer (NCT00005831) | National Cancer Institute (NCI) | 2000-03-01 |
| Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria (NCT00004988) | National Cancer Institute (NCI) | 2000-03-01 |
| Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy (NCT00005942) | National Cancer Institute (NCI) | 2000-03-01 |
| Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma (NCT00020111) | National Cancer Institute (NCI) | 2000-03-01 |
| Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer (NCT00005817) | National Cancer Institute (NCI) | 2000-03-01 |
| Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer (NCT00004635) | National Cancer Institute (NCI) | 2000-03-01 |
| Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM (NCT00004146) | National Cancer Institute (NCI) | 2000-03-01 |
| Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors (NCT00005604) | National Cancer Institute (NCI) | 2000-03-01 |
| Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572) | National Cancer Institute (NCI) | 2000-02-23 |
| Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy (NCT00026650) | National Cancer Institute (NCI) | 2000-02-14 |
| Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial (NCT00339950) | National Cancer Institute (NCI) | 2000-02-14 |
| Susceptibility to Breast Cancer (NCT00004565) | National Cancer Institute (NCI) | 2000-02-08 |
| Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer (NCT00005067) | National Cancer Institute (NCI) | 2000-02-01 |
| Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer (NCT00005085) | National Cancer Institute (NCI) | 2000-02-01 |
| Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer (NCT00004931) | National Cancer Institute (NCI) | 2000-02-01 |
| PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome (NCT00005064) | National Cancer Institute (NCI) | 2000-02-01 |
| Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 (NCT00004883) | National Cancer Institute (NCI) | 2000-02-01 |
| Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy (NCT00004547) | National Cancer Institute (NCI) | 2000-01-01 |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer (NCT00005065) | National Cancer Institute (NCI) | 2000-01-01 |
| Vaccine Therapy in Treating Patients With Advanced Adenocarcinoma of the Prostate (Prostate Cancer) (NCT00005039) | National Cancer Institute (NCI) | 2000-01-01 |
| Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer (NCT00004859) | National Cancer Institute (NCI) | 2000-01-01 |
| Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome (NCT00004918) | National Cancer Institute (NCI) | 1999-12-01 |
| Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors (NCT00004080) | National Cancer Institute (NCI) | 1999-12-01 |
| Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma (NCT00019682) | National Cancer Institute (NCI) | 1999-12-01 |
| Voriconazole to Treat Fungal Infections (NCT00001940) | National Cancer Institute (NCI) | 1999-12-01 |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery (NCT00020007) | National Cancer Institute (NCI) | 1999-12-01 |
| Vinorelbine and XR9576 to Treat Cancer (NCT00001944) | National Cancer Institute (NCI) | 1999-12-01 |
| Anti-Tac for Treatment of Leukemia (NCT00001941) | National Cancer Institute (NCI) | 1999-12-01 |
| Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy (NCT00004919) | National Cancer Institute (NCI) | 1999-12-01 |
| Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients (NCT00001937) | National Cancer Institute (NCI) | 1999-11-01 |
| Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia (NCT00006364) | National Cancer Institute (NCI) | 1999-11-01 |
| Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme (NCT00004262) | National Cancer Institute (NCI) | 1999-11-01 |
| Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (NCT00004101) | National Cancer Institute (NCI) | 1999-11-01 |
| Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick (NCT00339911) | National Cancer Institute (NCI) | 1999-11-01 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00005036) | National Cancer Institute (NCI) | 1999-11-01 |
| International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks (NCT00339274) | National Cancer Institute (NCI) | 1999-10-14 |